Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02674061
Title Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field